MENU
+Compare
GKOS
Stock ticker: NYSE
AS OF
Apr 4 closing price
Price
$83.65
Change
-$3.35 (-3.85%)
Capitalization
4.61B

GKOS Glaukos Corp Forecast, Technical & Fundamental Analysis

Glaukos Corp is an ophthalmic pharmaceutical and medical technology company focused on developing novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders, and retinal diseases... Show more

GKOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for GKOS with price predictions
Apr 04, 2025

GKOS's Indicator enters downward trend

The Aroon Indicator for GKOS entered a downward trend on March 19, 2025. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 143 similar instances where the Aroon Indicator formed such a pattern. In of the 143 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 28, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on GKOS as a result. In of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for GKOS turned negative on April 04, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 60 similar instances when the indicator turned negative. In of the 60 cases the stock turned lower in the days that followed. This puts the odds of success at .

The 50-day moving average for GKOS moved below the 200-day moving average on March 28, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where GKOS declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator demonstrates that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where GKOS advanced for three days, in of 344 cases, the price rose further within the following month. The odds of a continued upward trend are .

GKOS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. GKOS’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (9.970) is normal, around the industry mean (23.715). P/E Ratio (0.000) is within average values for comparable stocks, (83.458). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.667). Dividend Yield (0.000) settles around the average of (0.018) among similar stocks. P/S Ratio (14.327) is also within normal values, averaging (41.612).

View a ticker or compare two or three
GKOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

GKOS is expected to report earnings to fall 12.52% to -34 cents per share on April 30

Glaukos Corp GKOS Stock Earnings Reports
Q1'25
Est.
$-0.35
Q4'24
Missed
by $0.02
Q3'24
Beat
by $0.20
Q2'24
Est.
$-0.52
Q1'24
Missed
by $0.24
The last earnings report on February 20 showed earnings per share of -40 cents, missing the estimate of -37 cents. With 1.72M shares outstanding, the current market capitalization sits at 4.61B.
A.I. Advisor
published General Information

General Information

an ophthalmic medical device company

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
One Glaukos Way
Phone
+1 949 367-9600
Employees
907
Web
https://www.glaukos.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
XTN65.62-2.36
-3.48%
SPDR® S&P Transportation ETF
DFP18.93-0.97
-4.87%
FLAHERTY & CRUMRINE DYNAMIC PREFERRED AND Income FUND
RVT13.01-0.74
-5.38%
Royce Value Trust
PPI12.96-0.94
-6.80%
Astoria Real Asset ETF
IPOS11.68-1.12
-8.72%
Renaissance International IPO ETF

GKOS and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, GKOS has been loosely correlated with ISRG. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if GKOS jumps, then ISRG could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GKOS
1D Price
Change %
GKOS100%
-3.85%
ISRG - GKOS
46%
Loosely correlated
-8.70%
RDNT - GKOS
45%
Loosely correlated
-1.64%
NTRA - GKOS
44%
Loosely correlated
-3.49%
AORT - GKOS
43%
Loosely correlated
-3.81%
ALGN - GKOS
42%
Loosely correlated
-0.47%
More